Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases $12,468.82 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 20,111 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was acquired at an average cost of $0.62 per share, with a total value of $12,468.82. Following the completion of the acquisition, the chief executive officer now directly owns 14,875,244 shares of the company’s stock, valued at $9,222,651.28. This represents a 0.14 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Retractable Technologies Stock Performance

Shares of RVP traded down $0.01 during midday trading on Monday, reaching $0.61. 44,901 shares of the stock were exchanged, compared to its average volume of 85,288. Retractable Technologies, Inc. has a twelve month low of $0.56 and a twelve month high of $1.34. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. The company has a market capitalization of $18.38 million, a price-to-earnings ratio of -1.14 and a beta of 2.06. The business’s 50-day moving average price is $0.71 and its 200 day moving average price is $0.92.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Retractable Technologies in a report on Wednesday, November 27th. They issued a “hold” rating for the company.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent reporting period. 7.58% of the stock is owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.